Clinical trial
The Effect of Betahistine on Body Weight in Obese Subjects
NCT00409305 · OBEcure Ltd., Industry · Completed
Key facts
| NCT number | NCT00409305 |
|---|---|
| Title | The Effect of Betahistine on Body Weight in Obese Subjects |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Examine the Effect of Betahistine on Body Weight in Obese Subjects |
| Lead sponsor | OBEcure Ltd., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Behavioral, Drug |
| Interventions | Betahistine, Dietary counseling |
| Enrollment | 280 |
| Start date | Jan 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Dec 8, 2006 |
| Last update posted | Apr 21, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: